Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | PRCP | P42785 | 2/20 | 0.35 |
| ▸ | GLI1 | P08151 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.32 |
| ▸ | DPP4 | P27487 | 4/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | FAP | Q12884 | 1/20 | 0.31 |
| ▸ | ARG1 | P05089 | 1/20 | 0.30 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523066 | 0.94 | NOS2 (0.38) | NOS2NOS3NOS1PRCPGLI1 | |
| Proline SCHEMBL8428394 | 0.74 | NOS2 (0.47) | NOS2NOS3NOS1PRCPGLI1 | |
| SCHEMBL8062198 | 0.72 | NOS2 (0.46) | NOS2NOS3NOS1PRCPGLI1 | |
| Succinamide SCHEMBL9700026 | 0.72 | NOS2 (0.48) | NOS2NOS3NOS1PRCPGLI1 | |
| SCHEMBL7432758 | 0.72 | NOS2 (0.48) | NOS2NOS3NOS1PRCPGLI1 | |
| SCHEMBL10500400 | 0.70 | KMT2A (0.32) | KDM4EKMT2A | |
| SCHEMBL7899905 | 0.70 | SCN4A (0.35) | NOS2NOS3NOS1 | |
| SCHEMBL7400921 | 0.70 | NOS2 (0.41) | NOS2NOS3NOS1PRCPGLI1 | |
| SCHEMBL5389839 | 0.68 | FDPS (0.40) | NOS2NOS3NOS1KMT2AARG1 | |
| Hydrochloric Acid SCHEMBL7397745 | 0.68 | NOS2 (0.39) | NOS2NOS3NOS1PRCPGLI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120027859-A1 | Biodegradable Proline-Based Polymers | MEDIVAS, LLC | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120027859-A1 | Biodegradable Proline-Based Polymers | EPRS1, PRAP1, NPEPPS | NOS2 111/4885NOS3 152/4885NOS1 96/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.